Cargando…

PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells

Detalles Bibliográficos
Autores principales: Glodkowska-Mrowka, E, Manda-Handzlik, A, Stelmaszczyk-Emmel, A, Seferynska, I, Stoklosa, T, Przybylski, J, Mrowka, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742626/
https://www.ncbi.nlm.nih.gov/pubmed/26745851
http://dx.doi.org/10.1038/bcj.2015.109
_version_ 1782414227856687104
author Glodkowska-Mrowka, E
Manda-Handzlik, A
Stelmaszczyk-Emmel, A
Seferynska, I
Stoklosa, T
Przybylski, J
Mrowka, P
author_facet Glodkowska-Mrowka, E
Manda-Handzlik, A
Stelmaszczyk-Emmel, A
Seferynska, I
Stoklosa, T
Przybylski, J
Mrowka, P
author_sort Glodkowska-Mrowka, E
collection PubMed
description
format Online
Article
Text
id pubmed-4742626
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47426262016-02-22 PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells Glodkowska-Mrowka, E Manda-Handzlik, A Stelmaszczyk-Emmel, A Seferynska, I Stoklosa, T Przybylski, J Mrowka, P Blood Cancer J Commentary Nature Publishing Group 2016-01 2016-01-08 /pmc/articles/PMC4742626/ /pubmed/26745851 http://dx.doi.org/10.1038/bcj.2015.109 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Commentary
Glodkowska-Mrowka, E
Manda-Handzlik, A
Stelmaszczyk-Emmel, A
Seferynska, I
Stoklosa, T
Przybylski, J
Mrowka, P
PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells
title PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells
title_full PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells
title_fullStr PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells
title_full_unstemmed PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells
title_short PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells
title_sort pparγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742626/
https://www.ncbi.nlm.nih.gov/pubmed/26745851
http://dx.doi.org/10.1038/bcj.2015.109
work_keys_str_mv AT glodkowskamrowkae ppargligandsincreaseantileukemicactivityofsecondandthirdgenerationtyrosinekinaseinhibitorsinchronicmyeloidleukemiacells
AT mandahandzlika ppargligandsincreaseantileukemicactivityofsecondandthirdgenerationtyrosinekinaseinhibitorsinchronicmyeloidleukemiacells
AT stelmaszczykemmela ppargligandsincreaseantileukemicactivityofsecondandthirdgenerationtyrosinekinaseinhibitorsinchronicmyeloidleukemiacells
AT seferynskai ppargligandsincreaseantileukemicactivityofsecondandthirdgenerationtyrosinekinaseinhibitorsinchronicmyeloidleukemiacells
AT stoklosat ppargligandsincreaseantileukemicactivityofsecondandthirdgenerationtyrosinekinaseinhibitorsinchronicmyeloidleukemiacells
AT przybylskij ppargligandsincreaseantileukemicactivityofsecondandthirdgenerationtyrosinekinaseinhibitorsinchronicmyeloidleukemiacells
AT mrowkap ppargligandsincreaseantileukemicactivityofsecondandthirdgenerationtyrosinekinaseinhibitorsinchronicmyeloidleukemiacells